READ-ONLY DIGITIZATION RESULT
Cemiplimab monotherapy as first-line treatment of patients with brain metastases from advanced non-small cell lung cancer with programmed cell death-ligand 1 ≥50.
Cancer · 2025-May-15 · PMID 40323717
Panel B提取完成待 EXE 对齐验证
OS
FIGURE 1 Kaplan–Meier curves showing OS by the independent review committee in patients (A) with and (B) without brain metastases at baseline. Patients were stratified by tumor histology, with HR based on a stratified Cox regression model using the treatment as a covariate and tumor histology as a stratification factor. p values are two‐sided. CI indicates confidence interval; HR, hazard ratio; mOS, median overall survival; NE, not evaluable; OS, overall survival.
算法:legacy-0.5.0引擎:enhanced-linux
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | complete | 待验证 | 2 | 2026-07-18T20:12:01+00:00 |